IDEAYA Biosciences
IDYA
199 hedge funds and large institutions have $2.9B invested in IDEAYA Biosciences in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 91 increasing their positions, 61 reducing their positions, and 32 closing their positions.
49% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 61
2.95% more ownership
Funds ownership: 106.05% → 108.99% (+2.9%)
7% more call options, than puts
Call options by funds: $800K | Put options by funds: $748K
9% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 32
2% less funds holding
Funds holding: 204 → 199 (-5)
16% less capital invested
Capital invested by funds: $3.47B → $2.9B (-$572M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$44.1M |
| 2 |
BlackRock
New York
|
+$33.4M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$14.6M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$13M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$12.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$21.1M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15.9M |
| 3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$14.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$12.2M |
| 5 |
State Street
Boston,
Massachusetts
|
-$11.5M |
IDYA Hedge Fund Activity: Q2 2024 in Review
199 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q2 2024, worth a combined $2.9B — down 16% from $3.47B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of IDYA and 29 opened new positions — a net loss of 3 holders — while 61 trimmed existing stakes and 91 added.
The largest buyer was Fidelity Investments, adding an estimated $44.1M. The largest seller was Deerfield Management, cutting an estimated $21.1M.
- 199 institutional investors held IDEAYA Biosciences (IDYA) as of Q2 2024, down from 204 in Q1 2024.
- Funds reported $2.9B of IDEAYA Biosciences stock for Q2 2024, down 16% quarter-over-quarter.
- 29 funds opened new IDEAYA Biosciences positions in Q2 2024 and 32 closed out, a net change of -3 holders.
- The largest IDEAYA Biosciences buyer in Q2 2024 was Fidelity Investments, an estimated $44.1M added.
- The largest IDEAYA Biosciences seller in Q2 2024 was Deerfield Management, an estimated $21.1M sold.
Based on aggregated 13F filings for Q2 2024.